REVOLUTION MEDICINES INC (RVMD) Fundamental Analysis & Valuation

NASDAQ:RVMD • US76155X1000

Current stock price

99.12 USD
+0.48 (+0.49%)
At close:
99.12 USD
0 (0%)
After Hours:

This RVMD fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. RVMD Profitability Analysis

1.1 Basic Checks

  • RVMD had negative earnings in the past year.
  • RVMD had a negative operating cash flow in the past year.
  • RVMD had negative earnings in each of the past 5 years.
  • In the past 5 years RVMD always reported negative operating cash flow.
RVMD Yearly Net Income VS EBIT VS OCF VS FCFRVMD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -200M -400M -600M -800M -1B

1.2 Ratios

  • The Return On Assets of RVMD (-48.05%) is comparable to the rest of the industry.
  • RVMD has a Return On Equity (-69.35%) which is in line with its industry peers.
Industry RankSector Rank
ROA -48.05%
ROE -69.35%
ROIC N/A
ROA(3y)-30.89%
ROA(5y)-29.73%
ROE(3y)-39.91%
ROE(5y)-37.42%
ROIC(3y)N/A
ROIC(5y)N/A
RVMD Yearly ROA, ROE, ROICRVMD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 2025 -200 -400 -600

1.3 Margins

  • RVMD does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
RVMD Yearly Profit, Operating, Gross MarginsRVMD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 2025 -1K -2K -3K -4K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. RVMD Health Analysis

2.1 Basic Checks

  • Compared to 1 year ago, RVMD has more shares outstanding
  • Compared to 5 years ago, RVMD has more shares outstanding
  • The debt/assets ratio for RVMD is higher compared to a year ago.
RVMD Yearly Shares OutstandingRVMD Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
RVMD Yearly Total Debt VS Total AssetsRVMD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

2.2 Solvency

  • RVMD has an Altman-Z score of 13.84. This indicates that RVMD is financially healthy and has little risk of bankruptcy at the moment.
  • RVMD's Altman-Z score of 13.84 is amongst the best of the industry. RVMD outperforms 84.91% of its industry peers.
  • RVMD has a Debt/Equity ratio of 0.16. This is a healthy value indicating a solid balance between debt and equity.
  • RVMD's Debt to Equity ratio of 0.16 is on the low side compared to the rest of the industry. RVMD is outperformed by 64.99% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF N/A
Altman-Z 13.84
ROIC/WACCN/A
WACCN/A
RVMD Yearly LT Debt VS Equity VS FCFRVMD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B

2.3 Liquidity

  • RVMD has a Current Ratio of 7.14. This indicates that RVMD is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of RVMD (7.14) is better than 67.50% of its industry peers.
  • RVMD has a Quick Ratio of 7.14. This indicates that RVMD is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 7.14, RVMD is in the better half of the industry, outperforming 67.89% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 7.14
Quick Ratio 7.14
RVMD Yearly Current Assets VS Current LiabilitesRVMD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. RVMD Growth Analysis

3.1 Past

  • RVMD shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -65.55%.
EPS 1Y (TTM)-65.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-66.07%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • RVMD is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 24.93% yearly.
  • RVMD is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 284.00% yearly.
EPS Next Y-26.4%
EPS Next 2Y-4.68%
EPS Next 3Y4.8%
EPS Next 5Y24.93%
Revenue Next Year1132.72%
Revenue Next 2Y691.88%
Revenue Next 3Y463.33%
Revenue Next 5Y284%

3.3 Evolution

RVMD Yearly Revenue VS EstimatesRVMD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 2B 4B 6B 8B
RVMD Yearly EPS VS EstimatesRVMD Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 5 -5 10 15 20

More info and screens

Find the best growth stocksShow best growing peers

0

4. RVMD Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for RVMD. In the last year negative earnings were reported.
  • Also next year RVMD is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RVMD Price Earnings VS Forward Price EarningsRVMD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
RVMD Per share dataRVMD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-4.68%
EPS Next 3Y4.8%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. RVMD Dividend Analysis

5.1 Amount

  • No dividends for RVMD!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

RVMD Fundamentals: All Metrics, Ratios and Statistics

REVOLUTION MEDICINES INC

NASDAQ:RVMD (4/2/2026, 8:00:02 PM)

After market: 99.12 0 (0%)

99.12

+0.48 (+0.49%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-25
Earnings (Next)05-05
Inst Owners100.47%
Inst Owner Change-2.84%
Ins Owners1.82%
Ins Owner Change0.12%
Market Cap19.64B
Revenue(TTM)N/A
Net Income(TTM)-1.13B
Analysts87.41
Price Target136.84 (38.05%)
Short Float %7.58%
Short Ratio5.75
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-13.3%
Min EPS beat(2)-15.36%
Max EPS beat(2)-11.24%
EPS beat(4)0
Avg EPS beat(4)-10.23%
Min EPS beat(4)-15.36%
Max EPS beat(4)-1.54%
EPS beat(8)1
Avg EPS beat(8)-6.23%
EPS beat(12)3
Avg EPS beat(12)-5.8%
EPS beat(16)6
Avg EPS beat(16)-2.46%
Revenue beat(2)0
Avg Revenue beat(2)-100%
Min Revenue beat(2)-100%
Max Revenue beat(2)-100%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)10.02%
PT rev (3m)62.32%
EPS NQ rev (1m)-10.29%
EPS NQ rev (3m)-9.64%
EPS NY rev (1m)-10.43%
EPS NY rev (3m)-14.25%
Revenue NQ rev (1m)-9.67%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)43.61%
Revenue NY rev (3m)61.46%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 12.04
P/tB 12.58
EV/EBITDA N/A
EPS(TTM)-5.91
EYN/A
EPS(NY)-7.47
Fwd EYN/A
FCF(TTM)-4.61
FCFYN/A
OCF(TTM)-4.53
OCFYN/A
SpS0
BVpS8.23
TBVpS7.88
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -48.05%
ROE -69.35%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-30.89%
ROA(5y)-29.73%
ROE(3y)-39.91%
ROE(5y)-37.42%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 184.86%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 7.14
Quick Ratio 7.14
Altman-Z 13.84
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)148.83%
Cap/Depr(5y)163.7%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-65.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-66.07%
EPS Next Y-26.4%
EPS Next 2Y-4.68%
EPS Next 3Y4.8%
EPS Next 5Y24.93%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year1132.72%
Revenue Next 2Y691.88%
Revenue Next 3Y463.33%
Revenue Next 5Y284%
EBIT growth 1Y-71.48%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-40.29%
EBIT Next 3Y2.44%
EBIT Next 5Y23.57%
FCF growth 1Y-60.94%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-61.05%
OCF growth 3YN/A
OCF growth 5YN/A

REVOLUTION MEDICINES INC / RVMD Fundamental Analysis FAQ

What is the ChartMill fundamental rating of REVOLUTION MEDICINES INC (RVMD) stock?

ChartMill assigns a fundamental rating of 2 / 10 to RVMD.


What is the valuation status for RVMD stock?

ChartMill assigns a valuation rating of 0 / 10 to REVOLUTION MEDICINES INC (RVMD). This can be considered as Overvalued.


Can you provide the profitability details for REVOLUTION MEDICINES INC?

REVOLUTION MEDICINES INC (RVMD) has a profitability rating of 1 / 10.


What is the expected EPS growth for REVOLUTION MEDICINES INC (RVMD) stock?

The Earnings per Share (EPS) of REVOLUTION MEDICINES INC (RVMD) is expected to decline by -26.4% in the next year.